DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Van Cutsem E, Labianca R, Hossfeld D et al.
PETACC 3, Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3).
Journal of Clinical Oncology 2005; ASCO Annual Meeting Proceedings Abstract LBA8
We do not assume any responsibility for the contents of the web pages of other providers.